NASDAQ:SPRO | Operating Income | Spero Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$9.93M
2026-03-31-$7.54M
2025-12-31$31.41M
2025-09-30-$7.92M
2025-06-30-$2.44M
2025-03-31-$14.73M
2024-12-31-$21.73M
2024-09-30-$18.59M
2024-06-30-$19.06M
2024-03-31-$13.98M
2023-12-31$50.53M
2023-09-30-$1.93M
2023-06-30-$12.89M
2023-03-31-$14.23M
2022-12-31$25.92M
2022-09-30-$11.83M
2022-06-30-$26.08M
2022-03-31-$30.21M
2021-12-31-$27.5M
2021-09-30-$22.52M
2021-06-30-$18.54M
2021-03-31-$19.4M
2020-12-31-$18.8M
2020-09-30-$19.02M
2020-06-30-$18.48M
2020-03-31-$22.82M
2019-12-31-$25.88M
2019-09-30-$17.99M
2019-06-30-$13.65M
2019-03-31-$5.7M
2018-12-31-$11.08M
2018-09-30-$10.94M
2018-06-30-$9.97M
2018-03-31-$10.82M
2017-12-31-$14M
2017-09-30-$9.97M
2017-06-30-$10.17M
2017-03-31-$7.6M
2016-12-31-$8.81M
2016-09-30-$7.91M

Annual Operating Income

DateOperating Income
2025-12-31$6.31M
2024-12-31-$73.36M
2023-12-31$21.48M
2022-12-31-$42.2M
2021-12-31-$87.97M
2020-12-31-$79.11M
2019-12-31-$63.22M
2018-12-31-$42.81M
2017-12-31-$41.73M
2016-12-31-$33.22M
2015-12-31-$13.33M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.